dalteparin has been researched along with Carcinoma, Small Cell in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czerny, M | 1 |
| Fleck, T | 1 |
| Salat, A | 1 |
| Zimpfer, D | 1 |
| Klepetko, W | 1 |
| Wolner, E | 1 |
| Mueller, MR | 1 |
| Altinbas, M | 1 |
| Coskun, HS | 1 |
| Er, O | 1 |
| Ozkan, M | 1 |
| Eser, B | 1 |
| Unal, A | 1 |
| Cetin, M | 1 |
| Soyuer, S | 1 |
| Taccone, FS | 1 |
| Starc, JM | 1 |
| Sculier, JP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized, Phase III-b, Multi-centre, Open-label, Parallel Study of Enoxaparin (Low Molecular Weight Heparin) Given Concomitantly With Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Gastric and Gastro-oesophageal Cancer[NCT00718354] | Phase 3 | 740 participants (Actual) | Interventional | 2008-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for dalteparin and Carcinoma, Small Cell
| Article | Year |
|---|---|
Sealing of the mediastinum with a local hemostyptic agent reduces chest tube duration after complete mediastinal lymph node dissection for stage I and II non-small cell lung carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aprotinin; Carcinoma, Small Cell; Chest Tubes; Dalte | 2004 |
A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer.
Topics: Adult; Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; | 2004 |
1 other study available for dalteparin and Carcinoma, Small Cell
| Article | Year |
|---|---|
Splenic spontaneous rupture (SSR) and hemoperitoneum associated with low molecular weight heparin: a case report.
Topics: Aged; Anticoagulants; Carcinoma, Small Cell; Female; Fibrinolytic Agents; Hemoperitoneum; Heparin, L | 2003 |